Oncologic TherapiesEverett E. Vokes, Harvey M. Golomb Springer Science & Business Media, 2011 M06 28 - 659 páginas Our goal for this second edition of Oncologic Therapies is to again provide a brief introduction to the principles and practice of oncology and to oncologic therapies. The book provides a - scription of the major treatment modalities including surgery, radiation therapy, and systemic therapies including classic chemotherapy and biological therapies as well as a brief ov- view of supportive care and quality of life assessments. This is followed by a discussion of site-specific cancers covering the hematologic malignancies and solid tumors. Each chapter is designed to provide a brief discussion of background infor- tion including epidemiology,risk factors,and staging principles followed by a description of standard therapies according to stage as well as current investigational approaches. While the major pathological and clinical features of each disease are d- cussed,the emphasis of this book is clearly on the state of the art of standard and investigational therapies for each tumor type. As such,this book should be useful to general internists with an interest in oncology as well as housestaff and junior oncologists of all major oncologic modalities seeking a brief and focused patient management resource. References providing more - depth discussion for each field are also provided. We rec- mend that any information pertaining to specific chemotherapy regimens and dosing be confirmed in a primary reference since we cannot exclude the possibility of an occasional typograp- cal error. |
Contenido
3 | |
9 | |
19 | |
Principles of Cancer Chemoprevention | 67 |
Principles of Cancer Immunotherapy | 79 |
Ethics and the Development of New Oncologic Therapies Informed Consent Equipoise and the Randomized Trial | 95 |
103 | |
Diagnosis and Management of Oncologic Emergencies | 105 |
Breast Cancer | 329 |
Locally Advanced Locally Recurrent and Metastatic Breast Cancer | 341 |
Tumors of the Head and Neck | 355 |
Carcinoma of the Esphogus | 373 |
Lung Cancer | 387 |
Small Cell Lung Cancer | 405 |
Mesothelioma | 413 |
Mesothelioma | 423 |
Infectious Complications of Oncologic Therapy | 115 |
Hematopoietic Growth Factors | 125 |
Pain Management | 139 |
ChemotherapyInduced Nausea and Vomiting | 149 |
Pleural Effusions | 163 |
Measuring Quality of Life | 171 |
181 | |
Acute Leukemia | 183 |
Chronic Myelogenous Leukemia | 211 |
Chronic Lymphocytic Leukemia | 229 |
Myelodysplastic Syndromes | 241 |
Myeloproliferative Disorders | 253 |
Hairy Cell Leukemia | 261 |
Hodgkins Lymphoma | 267 |
Cutaneous T Cell Lymphomas | 281 |
NonHodgkins Lymphoma | 293 |
Multiple Myeloma and Other Plasma Cell Dyscrasias | 317 |
327 | |
Colorectal Cancer | 437 |
Anal Cancers | 449 |
Gastric Cancer 33 Gastric Cancer | 459 |
Hepatobillary Cancer | 487 |
Testicular Cancer | 497 |
Renal Cancer | 511 |
Genitourinary Malignancies BladderPenisUrethral Cancers | 519 |
Gynecologic Cancers | 529 |
Cervical Vulvar and Vaginal Cancer | 543 |
Ovarian Cancer | 561 |
Brain Tumors | 567 |
Sarcomas | 585 |
SoftTissue Sarcomas | 595 |
607 | |
Skin Cancers | 625 |
NonMelanoma Skin Neoplasms | 641 |
Subject Index | 647 |
Otras ediciones - Ver todas
Términos y frases comunes
activity acute addition adjuvant agents amphotericin analysis approach assessment associated benefit biopsy Blood breast cancer cell chemotherapy chronic cisplatin Clin Oncol clinical clinical trials combination common compared complete considered cycles demonstrated diagnosis disease dose drug early effects effusions et al evaluation factors followed gene Group growth half-life high-dose human ifosfamide imatinib important improved incidence increased initial invasive involvement lesions less leukemia levels locally lung cancer lymph node lymphoma major malignant median melanoma ment metastatic mg/m² months neck Oncology overall pain patients phase pleural present primary prognostic radiation radiotherapy randomized randomized trial receiving recent recurrence regimens reported resection response risk role sarcoma significant stage standard surgery surgical survival symptoms syndrome Table therapy thyroid tients tion tissue toxicity transplantation treated treatment tumor usually versus vincristine weeks